HRMY
$29.35
Revenue | $168.41Mn |
Net Profits | $26.61Mn |
Net Profit Margins | 15.8% |
Harmony Biosciences Holdings Inc’s revenue jumped 31.26% since last year same period to $168.41Mn in the Q4 2023. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 5.08% jump in its revenue since last 3-months.
Harmony Biosciences Holdings Inc’s net profit fell -45.15% since last year same period to $26.61Mn in the Q4 2023. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated -30.82% fall in its net profits since last 3-months.
Harmony Biosciences Holdings Inc’s net profit margin fell -58.21% since last year same period to 15.8% in the Q4 2023. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated -34.17% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.62 |
EPS Estimate Current Year | 0.62 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 0.62 - a 29.17% jump from last quarter’s estimates.
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current year stand at 0.62.
Earning Per Share (EPS) | 0.45 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) fell -43.04% since last year same period to 0.45 in the Q4 2023. This indicates that the Harmony Biosciences Holdings Inc has generated -43.04% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-02-22 | 0.48 | 0.45 | -6.25% |
2023-05-02 | 0.47 | 0.66 | 40.43% |
2023-10-31 | 0.65 | 0.75 | 15.38% |
2023-08-01 | 0.63 | 0.56 | -11.11% |